UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
ReposiTrak
TRAK
$159M
| $2.77M | ﹤0.01% |
125,103
+19,471
| +18% | +$412K |
|
4402
Cohen & Steers Closed End Opportunity Fund
FOF
$380M
| $2.77M | ﹤0.01% |
217,826
-13,211
| -6% | -$171K |
|
4403
CALL
Steel Dynamics
STLD
$37.6B
| $2.76M | ﹤0.01% |
+24,200
| New | +$3.22M |
|
4404
Towne Bank
TOWN
$3.42B
| $2.75M | ﹤0.01% |
80,832
+23,932
| +42% | +$832K |
|
4405
iShares MSCI Israel ETF
EIS
$909M
| $2.75M | ﹤0.01% |
35,678
+27,214
| +322% | +$1.94M |
|
4406
Kura Oncology
KURA
$850M
| $2.75M | ﹤0.01% |
315,475
+185,659
| +143% | +$2.67M |
|
4407
CALL
Cardiff Oncology
CRDF
$77.2M
| $2.75M | ﹤0.01% |
633,000
| – | – |
|
4408
AdaptHealth
AHCO
$759M
| $2.75M | ﹤0.01% |
288,429
+248,886
| +629% | +$2.52M |
|
4409
Camden National
CAC
$976M
| $2.74M | ﹤0.01% |
64,178
+3,869
| +6% | +$171K |
|
|
NVEE
4410
DELISTED
NV5 Global
NVEE
| $2.74M | ﹤0.01% |
145,561
+70,129
| +93% | +$1.54M |
|
|
VSXY
4411
CALL
Victoria's Secret
VSXY
$7.83B
| $2.73M | ﹤0.01% |
66,000
-500
| -0.8% | -$17.7K |
|
4412
JPMorgan Short Duration Core Plus ETF
JSCP
$1.71B
| $2.73M | ﹤0.01% |
58,549
+13,153
| +29% | +$617K |
|
|
RMMZ
4413
RiverNorth Managed Duration Municipal Income Fund II
RMMZ
$126M
| $2.73M | ﹤0.01% |
182,705
+40,760
| +29% | +$646K |
|
4414
C4 Therapeutics
CCCC
$412M
| $2.73M | ﹤0.01% |
757,852
+423,771
| +127% | +$2.11M |
|
|
TBN
4415
Tamboran Resources
TBN
$1.17B
| $2.72M | ﹤0.01% |
129,654
+126,495
| +4,004% | +$2.32M |
|
4416
Pacific Biosciences
PACB
$368M
| $2.72M | ﹤0.01% |
1,486,015
+843,166
| +131% | +$1.65M |
|
4417
Lakeland Financial Corp
LKFN
$1.53B
| $2.72M | ﹤0.01% |
39,504
+18,088
| +84% | +$1.25M |
|
4418
Weave Communications
WEAV
$423M
| $2.71M | ﹤0.01% |
170,183
+91,045
| +115% | +$1.28M |
|
4419
Westamerica Bancorp
WABC
$1.37B
| $2.71M | ﹤0.01% |
51,637
+9,224
| +22% | +$494K |
|
|
CET
4420
Central Securities Corp
CET
$1.65B
| $2.71M | ﹤0.01% |
59,286
+1,366
| +2% | +$63.8K |
|
4421
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$358M
| $2.7M | ﹤0.01% |
55,858
-6,448
| -10% | -$324K |
|
4422
CALL
XPeng
XPEV
$11.6B
| $2.7M | ﹤0.01% |
228,698
+202,300
| +766% | +$2.5M |
|
|
ETX
4423
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
| $2.69M | ﹤0.01% |
152,942
+9,023
| +6% | +$166K |
|
4424
Palomar
PLMR
$3.45B
| $2.69M | ﹤0.01% |
25,486
+8,684
| +52% | +$881K |
|
4425
Invesco China Technology ETF
CQQQ
$3.22B
| $2.69M | ﹤0.01% |
68,184
+23,912
| +54% | +$994K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.